Status | Study |
RECRUITING |
Study Name: Multidisciplinary Approach to Reduce Cardiovascular Health Disparities Condition: Acute Coronary Syndrome Date: 2023-12-05 Interventions: Based on obtained subjective and objective data from patient-filled questionnaire and laboratory testing respectively, lifestyle and medication recomm |
RECRUITING |
Study Name: Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS Condition: Acute Coronary Syndrome Date: 2023-06-15 Interventions: Cholesterol Ester Transfer Protein Inhibitor, 300 mg tablets |
ACTIVE_NOT_RECRUITING |
Study Name: Role of FFR in ACS Patients: Pressure ACS Registry Condition: Date: 2023-05-31 Interventions: Functional assessement of anatomical stenosis of coronary artery |
RECRUITING |
Study Name: Symptoms of Acute Coronary Syndrome in Medical Regulation Condition: Date: 2023-05-22 Interventions: Analysis of the differences in symptoms of a myocardial infarction between a man and a woman |
RECRUITING |
Study Name: A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome Condition: Acute Coronary Syndrome Date: 2023-02-23 Interventions: Milvexian will be administered orally. |
RECRUITING |
Study Name: Platelet Sub-study of the Neomindset Trial Condition: Acute Coronary Syndrome Date: 2023-02-15 Interventions: Acetylsalicylic acid (100 mg/day) + ticagrelor (90 mg twice daily) Or Acetylsalicylic acid (100 mg/day) + prasugrel (10 mg once daily) |
COMPLETED |
Study Name: Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome Condition: Acute Coronary Syndrome Date: 2022-09-15 Interventions: Oral and written information emphasise the benefits of cardiac rehabilitation in terms of treatment of heart diseases, increasing functional c |
Active, not recruiting |
Study Name: Pre-hospital Rule-out of Acute Coronary Syndrome Condition: Acute Coronary Syndrome Date: 2022-07-17 Interventions: Interventional |
RECRUITING |
Study Name: LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos Condition: Acute Coronary Syndrome Date: 2022-03-22 |
RECRUITING |
Study Name: Rivaroxaban in Left Ventricular Thrombus Condition: Acute Coronary Syndrome Date: 2021-07-10 Interventions: Dose of 20 mg once a day for three months followed by transthoracic echocardiographic assessment for presence/absence of LV thrombus after 4 week |